Skip to main content
Figure 4 | BMC Immunology

Figure 4

From: A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection

Figure 4

Plasma concentration versus time profiles of SCH 546738 in Lewis rat and C57BL/6 mouse. SCH 546738 in 0.4% methylcellulose was administered orally at 10 mg/kg (mpk) in Lewis rats or 30 mpk in C57BL/6 mice. The plasma concentration of SCH 546738 in the blood was calculated as the mean of 3 animals (n = 3) at indicated time points post-dose. Their AUC from 0 to 24 hr is also calculated and indicated.

Back to article page